BridgeMD
New treatment option for Muscle Invasive Bladder Cancer
Official title Effect of Neoadjuvant Chemotherapy on MRI Accuracy Before Cystectomy
ClinicalTrials.gov ID: NCT07202819
What this study is testing
What is Neoadjuvant Chemotherapy?
Neoadjuvant Chemotherapy is an investigational medicine, being studied as a potential treatment for muscle invasive bladder cancer.
Also referred to as NAC.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- The goal of this clinical trial is to learn if neoadjuvant chemotherapy (NAC) affects the accuracy of magnetic resonance imaging (MRI) in staging muscle-invasive bladder cancer (MIBC). This study will also assess how tissue changes induced by NAC impact MRI interpretation.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Patients diagnosed with cT2 urothelial carcinoma of the urinary bladder, according to the TNM classification, who give informed, written consent on...
You likely can't join if
- Patients who have received pelvic radiotherapy.
- Previous open or laparoscopic pelvic surgery.
- Patients with contraindications to MRI.
- Patients who are unfit for or refuse radical cystectomy.
- Ineligibility to cisplatin.
- squamous differentiation in the histopathology
The study team makes the final eligibility decision.
Where it's taking place
- Asyut, Asyut Governorate, Egypt
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Asyut, Asyut Governorate, Egypt. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.